IL164391A0 - Medicaments containing steroids and a novel anticholinesterase drug - Google Patents

Medicaments containing steroids and a novel anticholinesterase drug

Info

Publication number
IL164391A0
IL164391A0 IL16439103A IL16439103A IL164391A0 IL 164391 A0 IL164391 A0 IL 164391A0 IL 16439103 A IL16439103 A IL 16439103A IL 16439103 A IL16439103 A IL 16439103A IL 164391 A0 IL164391 A0 IL 164391A0
Authority
IL
Israel
Prior art keywords
medicaments containing
containing steroids
anticholinesterase drug
novel
novel anticholinesterase
Prior art date
Application number
IL16439103A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL164391A0 publication Critical patent/IL164391A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16439103A 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug IL164391A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
PCT/EP2003/003668 WO2003086399A1 (fr) 2002-04-12 2003-04-09 Medicament contenant des steroides et un nouvel anticholinergique

Publications (1)

Publication Number Publication Date
IL164391A0 true IL164391A0 (en) 2005-12-18

Family

ID=28458802

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16439103A IL164391A0 (en) 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug
IL164391A IL164391A (en) 2002-04-12 2004-10-04 Medicaments containing steroids and a novel anticholinesterase drug optionally as propellant-containing inhalable aerosol

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL164391A IL164391A (en) 2002-04-12 2004-10-04 Medicaments containing steroids and a novel anticholinesterase drug optionally as propellant-containing inhalable aerosol

Country Status (29)

Country Link
EP (2) EP1621197A3 (fr)
JP (1) JP4559086B2 (fr)
KR (1) KR101010869B1 (fr)
CN (1) CN1646126A (fr)
AR (1) AR039275A1 (fr)
AT (1) ATE312607T1 (fr)
AU (1) AU2003216921B2 (fr)
BR (1) BR0309085A (fr)
CA (1) CA2481268C (fr)
DE (2) DE10216429A1 (fr)
DK (1) DK1496902T3 (fr)
EA (1) EA008386B1 (fr)
EC (1) ECSP045355A (fr)
ES (1) ES2254917T3 (fr)
HR (1) HRP20040943B1 (fr)
IL (2) IL164391A0 (fr)
ME (1) MEP54208A (fr)
MX (1) MXPA04009917A (fr)
MY (1) MY137045A (fr)
NO (1) NO20044097L (fr)
NZ (1) NZ536284A (fr)
PE (1) PE20040326A1 (fr)
PL (1) PL211227B1 (fr)
RS (1) RS50776B (fr)
TW (1) TWI311055B (fr)
UA (1) UA80125C2 (fr)
UY (1) UY27758A1 (fr)
WO (1) WO2003086399A1 (fr)
ZA (1) ZA200406751B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
AR033290A1 (es) 2001-04-30 2003-12-10 Glaxo Group Ltd Derivados antiinflamatorios de androstano
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
ES2413011T3 (es) 2004-02-06 2013-07-15 Meda Pharma Gmbh & Co. Kg Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
PT2435025T (pt) 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
KR19990008109A (ko) * 1995-04-28 1999-01-25 나가사까 겐지로 1,4-이치환 피페리딘 유도체
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
CA2733294C (fr) * 2000-10-31 2011-12-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combinaison pharmaceutique constituee d'un sel de tiotropium et de ciclesonide

Also Published As

Publication number Publication date
UY27758A1 (es) 2003-11-28
JP4559086B2 (ja) 2010-10-06
PE20040326A1 (es) 2004-07-13
PL211227B1 (pl) 2012-04-30
RS50776B (sr) 2010-08-31
EP1621197A2 (fr) 2006-02-01
EA200401303A1 (ru) 2005-04-28
EA008386B1 (ru) 2007-04-27
CA2481268C (fr) 2011-07-12
TW200403062A (en) 2004-03-01
NO20044097L (no) 2004-11-04
PL371561A1 (en) 2005-06-27
DE50301934D1 (de) 2006-01-19
JP2005529105A (ja) 2005-09-29
HRP20040943A2 (en) 2005-04-30
AR039275A1 (es) 2005-02-16
ES2254917T3 (es) 2006-06-16
UA80125C2 (en) 2007-08-27
ATE312607T1 (de) 2005-12-15
WO2003086399A1 (fr) 2003-10-23
EP1496902B1 (fr) 2005-12-14
CA2481268A1 (fr) 2003-10-23
HRP20040943B1 (hr) 2013-05-31
MXPA04009917A (es) 2004-12-07
ECSP045355A (es) 2005-01-28
AU2003216921B2 (en) 2008-03-13
KR20050000391A (ko) 2005-01-03
KR101010869B1 (ko) 2011-01-26
EP1496902A1 (fr) 2005-01-19
TWI311055B (en) 2009-06-21
DK1496902T3 (da) 2006-05-08
MY137045A (en) 2008-12-31
MEP54208A (en) 2011-05-10
NZ536284A (en) 2006-11-30
BR0309085A (pt) 2005-02-09
DE10216429A1 (de) 2003-10-23
AU2003216921A1 (en) 2003-10-27
ZA200406751B (en) 2006-12-27
RS89904A (sr) 2006-10-27
CN1646126A (zh) 2005-07-27
IL164391A (en) 2010-11-30
EP1621197A3 (fr) 2010-01-06

Similar Documents

Publication Publication Date Title
EP1581281A4 (fr) Inhalateur degageant un medicament en aerosol
IL166747A0 (en) Water-soluble iron-carbohydrate complexes production thereof and medicaments containing said complexes
EP1581281A3 (fr) Inhalateur degageant un medicament en aerosol
IL162700A0 (en) Medicament dispenser
GB0217198D0 (en) Medicament dispenser
GB0217196D0 (en) Medicament dispenser
GB0217199D0 (en) Medicament dispenser
GB0216831D0 (en) Medicament dispenser
GB0209526D0 (en) Medicament dispenser
PL371561A1 (en) Medicaments containing steroids and a novel anticholinesterase drug
AU2002257562A1 (en) Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
GB0206861D0 (en) Medicaments
HRP20041193A2 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
GB0211578D0 (en) Medicaments
GB2409645B (en) Flower essence-containing medicaments
GB0209528D0 (en) Medicament dispenser
AUPS286302A0 (en) Medication inhaler
AU2002367117A1 (en) A medicine dispensing system and components thereof
ZA200406881B (en) Medicaments containing betamimetic drugs and a novel anticholineterase drug
AU2003246489A8 (en) Oral delivery system containing a gel matrix and liposomes
PL376744A1 (pl) Tabletki farmaceutyczne zawierające tibolon i powłoczkę
GB2383988B (en) Pill dispenser
AU2003268724B2 (en) Isoquinoline compounds and medicinal use thereof
HRP20050430A2 (en) Pharmaceutical tablets containing tibolone and a coating
AU2003229137A8 (en) Medication inhaler